Atlas Trials

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Clinical trial NCT04680988 · COMPLETED

Trial details

NCT number
NCT04680988
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent or Metastatic Cervical Cancer
Start date
2021-04-05
Primary completion
2025-07-07
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.